PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to test the effects of PHENOGENE-1A, which is the treatment under investigation in this study. This research will investigate if PHENOGENE-1A can help people with ALS by measuring their function using the ALS Functional Rating Scale Revised (ALSFRS-R), measuring lung function using pulmonary function tests (PFTs), such as forced vital capacity (FVC), and measuring neuro-inflammatory biomarkers in the blood.
Epistemonikos ID: d99102a89d57445fd972e0ec3b322fa4bbd4136c
First added on: Aug 27, 2025